Jesús María
Hernández Rivas
Catedrático de Universidad
![Foto de Jesús María](/img/uploaded/22eccb650f0a1f4a59fe4629ca87e13e.jpg)
![Foto de Hospital General Universitario Gregorio Marañón](/img/noimage_org.png)
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (9)
2024
-
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial
Haematologica, Vol. 109, Núm. 2, pp. 543-552
2021
-
Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)
Leukemia Research, Vol. 109
-
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia
Blood, Vol. 137, Núm. 14, pp. 1879-1894
2016
-
Incidence, clinical and biological characteristics and outcome of secondary acute lymphoblastic leukemia after solid organ or hematologic malignancy
Leukemia & lymphoma, Vol. 57, Núm. 1, pp. 86-91
-
The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab
British journal of haematology, Vol. 172, Núm. 3, pp. 428-438
2015
-
Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations
British Journal of Haematology
2014
-
Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm
Leukemia, Vol. 28, Núm. 4, pp. 823-829